TRPV4 and Sepsis: To evaluate the role of TRPV4 channels in sepsis, we used the highly selective inhibitors, GSK2193874 (hereafter GSK219)33 and HC067047 (hereafter HC067)28, 39, which have been shown to be well tolerated in vivo, with minimal side effects33, 39.